Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XV6L
|
|||
| Former ID |
DIB006521
|
|||
| Drug Name |
Kanglaite
|
|||
| Indication | Cachexia [ICD-11: MG20; ICD-10: R64; ICD-9: 799.4] | Phase 1 | [1] | |
| Company |
KangLaiTe USA Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00031031) Kanglaite Injection Phase I Study. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.